Author Question: When can a seller's investment in reducing transaction cost increase the price of the product to ... (Read 59 times)

ETearle

  • Hero Member
  • *****
  • Posts: 580
When can a seller's investment in reducing transaction cost increase the price of the product to customers but still leave them better off?

Question 2

Which of the following is uncharacteristic of monopolistic competition in the long run?
 a. a large number of sellers in the industry
  b. zero economic profits
 c. price in excess of marginal cost
 d. firms have no excess capacity



Galvarado142

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

When the seller tries to reduce transaction cost through informative advertising, the customer's cost of acquiring information reduces, thereby making them better off.

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library